News

The system will be used to examine genes for diabetes-related traits and to investigate genetic variants affecting skeletal muscle hypertrophy.

ARTES will apply its Hansenula technology platform and know-how to the generation of production cell lines, analytical assay development, and lab-scale fermentation.

The redesigned site supports AMRI’s ongoing globalization initiatives and reinforces the company’s evolution over 16 years into a global contract services and R&D organization.

AbD Serotec has announced the publication of a scientific research paper in Journal of Virology from one of its customers.

Genedata will create a global scientific computing infrastructure for the lead discovery and drug research programs at Nycomed sites worldwide.

Both companies announced the strengthening of their partnership through MMI's adoption of Sequenom's MassARRAY® and iPLEX™ foundation technologies.

The University of Nottingham is set to become a world leader in ‘clean’ chemistry and engineering with the opening of a new multi-million pound research initiative.

Both companies have reached an agreement to collaborate on oncology biospecimen procurement and management.

Galapagos NV's service division BioFocus DPI has extended its drug discovery agreement with Eli Lilly and Company until end 2008.

Significant developments have been reported by Uniqsis to develop a new concept in flow chemistry, leading to the launch of the FlowSyn™ Continuous Flow Reactor at the end of last year.